Deutsche Bank’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-21,402
| Closed | -$185K | – | 4076 |
|
2022
Q1 | $185K | Sell |
21,402
-2,004
| -9% | -$17.3K | ﹤0.01% | 3287 |
|
2021
Q4 | $334K | Buy |
23,406
+4,679
| +25% | +$66.8K | ﹤0.01% | 3060 |
|
2021
Q3 | $411K | Buy |
18,727
+1,578
| +9% | +$34.6K | ﹤0.01% | 3157 |
|
2021
Q2 | $229K | Buy |
+17,149
| New | +$229K | ﹤0.01% | 3672 |
|
2020
Q1 | – | Sell |
-3,103
| Closed | -$15K | – | 4387 |
|
2019
Q4 | $15K | Buy |
+3,103
| New | +$15K | ﹤0.01% | 4197 |
|
2019
Q2 | – | Sell |
-10,527
| Closed | -$38K | – | 4930 |
|
2019
Q1 | $38K | Buy |
+10,527
| New | +$38K | ﹤0.01% | 4405 |
|
2018
Q4 | – | Sell |
-23,345
| Closed | -$114K | – | 4801 |
|
2018
Q3 | $114K | Buy |
23,345
+5,745
| +33% | +$28.1K | ﹤0.01% | 4294 |
|
2018
Q2 | $131K | Sell |
17,600
-7,314
| -29% | -$54.4K | ﹤0.01% | 4288 |
|
2018
Q1 | $162K | Sell |
24,914
-9,694
| -28% | -$63K | ﹤0.01% | 4155 |
|
2017
Q4 | $311K | Buy |
34,608
+5,174
| +18% | +$46.5K | ﹤0.01% | 3700 |
|
2017
Q3 | $292K | Buy |
29,434
+29,429
| +588,580% | +$292K | ﹤0.01% | 3581 |
|
2017
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 4531 |
|
2017
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 4510 |
|
2016
Q4 | $0 | Sell |
5
-5,000
| -100% | – | ﹤0.01% | 4496 |
|
2016
Q3 | $36K | Buy |
5,005
+3,942
| +371% | +$28.4K | ﹤0.01% | 4044 |
|
2016
Q2 | $8K | Sell |
1,063
-437
| -29% | -$3.29K | ﹤0.01% | 4562 |
|
2016
Q1 | $9K | Buy |
1,500
+1,405
| +1,479% | +$8.43K | ﹤0.01% | 4494 |
|
2015
Q4 | $0 | Buy |
+95
| New | – | ﹤0.01% | 4796 |
|